Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06001853 · ClinicalTrials.gov registry record · Phase 2
Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy
A Phase 2 study of Facet-Mediated Low Back Pain, sponsored by Mayo Clinic.
- Active
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06001853: Active Phase 2 study of Facet-Mediated Low Back Pain, sponsored by Mayo Clinic.
NCT06001853 is a Phase 2 study of Facet-Mediated Low Back Pain that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06001853, a Phase 2 study of Facet-Mediated Low Back Pain, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate the safety and effect of bone marrow-derived stem cells for the treatment of low back pain.
Primary Outcome
Clinical examination face-to-face during follow-up visits
Conditions Studied
Interventions
- DRUG BM-MSC injection
- DRUG DSMO Injection
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-11-03 |
| Est. Completion | 2026-07 |
| Phase | Phase 2 |
What the registry record for NCT06001853 still lists
NCT06001853 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Facet-Mediated Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which BM-MSC injection is the first listed.
NCT06001853 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06001853 about?
NCT06001853 is a clinical study titled "Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy". The purpose of this research study is to evaluate the safety and effect of bone marrow-derived stem cells for the treatment of low back pain.
What is the current status of trial NCT06001853?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2023-11-03. Estimated completion is 2026-07.
What conditions does trial NCT06001853 study?
This clinical trial studies the following conditions: Facet-Mediated Low Back Pain.
What interventions are being tested in trial NCT06001853?
The interventions under investigation include: BM-MSC injection (DRUG), DSMO Injection (DRUG).
Who is sponsoring clinical trial NCT06001853?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06001853 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facet-Mediated Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06001853's enrollment target sits among peer trials
40 1362nd of 2000 higher than 542 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI